West Chester Capital Advisors, Inc Abb Vie Inc. Transaction History

West Chester Capital Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $10,845 - $12,490	-75 Reduced 4.23%	1,700 $270,000
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $26,842 - $30,786	-200 Reduced 10.13%	1,775 $238,000
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $7,706 - $9,797	-56 Reduced 2.76%	1,975 $302,000
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $13,300 - $15,097	-125 Reduced 5.8%	2,031 $219,000
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $6,312 - $7,032	-60 Reduced 2.71%	2,156 $243,000
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $1,125 - $1,238	11 Added 0.5%	2,216 $240,000
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $177,480 - $239,617	2,205 New	2,205 $236,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on West Chester Capital Advisors, Inc with notifications on news.